AU2823395A - Novel compounds useful in modulating gene expression of retinoid responsive genes and/or having anti-ap-1 activity - Google Patents
Novel compounds useful in modulating gene expression of retinoid responsive genes and/or having anti-ap-1 activityInfo
- Publication number
- AU2823395A AU2823395A AU28233/95A AU2823395A AU2823395A AU 2823395 A AU2823395 A AU 2823395A AU 28233/95 A AU28233/95 A AU 28233/95A AU 2823395 A AU2823395 A AU 2823395A AU 2823395 A AU2823395 A AU 2823395A
- Authority
- AU
- Australia
- Prior art keywords
- activity
- gene expression
- novel compounds
- compounds useful
- responsive genes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/04—Five-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US326775 | 1989-03-21 | ||
| US25534594A | 1994-06-07 | 1994-06-07 | |
| US32677594A | 1994-10-20 | 1994-10-20 | |
| US46803595A | 1995-06-06 | 1995-06-06 | |
| US468035 | 1995-06-06 | ||
| PCT/US1995/007390 WO1995033745A2 (en) | 1994-06-07 | 1995-06-07 | Novel compounds useful in modulating gene expression of retinoid responsive genes and/or having anti-ap-1 activity |
| US255345 | 1999-02-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2823395A true AU2823395A (en) | 1996-01-04 |
Family
ID=27400851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU28233/95A Abandoned AU2823395A (en) | 1994-06-07 | 1995-06-07 | Novel compounds useful in modulating gene expression of retinoid responsive genes and/or having anti-ap-1 activity |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2823395A (en) |
| WO (1) | WO1995033745A2 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7329741B2 (en) * | 1996-06-05 | 2008-02-12 | Chiron Corporation | Polynucleotides that hybridize to DP-75 and their use |
| JP2000511558A (en) * | 1996-06-21 | 2000-09-05 | アラーガン・セイルズ・インコーポレイテッド | Substituted tetrahydronaphthalene and dihydronaphthalene derivatives having retinoid and / or retinoid antagonist-like biological activity |
| FR2752734B1 (en) * | 1996-09-02 | 1998-11-06 | Cird Galderma | USE OF RETINOIDS FOR THE PREPARATION OF A MEDICAMENT FOR TREATING CONDITIONS RELATED TO VEGF OVEREXPRESSION |
| DE19708461A1 (en) * | 1997-02-18 | 1998-08-27 | Meulen Volker Prof Dr Ter | Use of aminergic substances to prepare medicaments |
| CN1301156A (en) * | 1997-11-12 | 2001-06-27 | 弗·哈夫曼-拉罗切有限公司 | Treatment of T-Helper cell tyre 2 mediated immune diseases with retinoid antagonists |
| PT1324970E (en) | 2000-10-02 | 2009-01-02 | Hoffmann La Roche | Retinoids for the treatment of emphysema |
| US20040131648A1 (en) * | 2002-10-24 | 2004-07-08 | The Procter & Gamble Company | Nuclear hormone receptor compounds, products and methods employing same |
| BRPI0711155A2 (en) | 2006-05-02 | 2011-08-23 | Anacor Pharmaceuticals Inc | hydrolytically resistant boron-containing treatments and methods of use |
| KR101587687B1 (en) * | 2012-04-27 | 2016-01-21 | 가톨릭대학교 산학협력단 | Composition for preventing or treating immune disease comprising SR11302 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU86022A1 (en) * | 1985-07-25 | 1987-02-04 | Cird | POLYCYLIC AROMATIC DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION IN THE PHARMACEUTICAL AND COSMETIC FIELDS |
| FR2601670B1 (en) * | 1986-07-17 | 1988-10-07 | Cird | NOVEL AROMATIC BICYCLIC DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR USE IN HUMAN AND VETERINARY MEDICINE AND IN COSMETICS |
| EP0552302A4 (en) * | 1990-10-10 | 1993-11-10 | La Jolla Cancer Research Foundation | Method of inhibiting transcription utilizing nuclear receptors |
| WO1993021146A1 (en) * | 1992-04-22 | 1993-10-28 | Ligand Pharmaceuticals Incorporated | Compounds having selectivity for retinoid x receptors |
-
1995
- 1995-06-07 WO PCT/US1995/007390 patent/WO1995033745A2/en active Application Filing
- 1995-06-07 AU AU28233/95A patent/AU2823395A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1995033745A3 (en) | 1996-05-02 |
| WO1995033745A2 (en) | 1995-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2095599A (en) | Human genes and gene expression products i | |
| AU690251B2 (en) | Cosmetic compositions having keratolytic and anti-acne activity | |
| AU4053699A (en) | Novel human genes and gene expression products | |
| AU7212494A (en) | Hybridization and sequencing of nucleic acids | |
| AU2820595A (en) | Colon specific genes and proteins | |
| AU4231693A (en) | Methods and compositions modulating ribonucleic acid expression | |
| AU4187499A (en) | Human genes and gene expression products v | |
| AU5730896A (en) | Fucosyltransferase genes and uses thereof | |
| AU6623896A (en) | Detection of nucleic acids and nucleic acid units | |
| AU7435296A (en) | Novel expression vectors and methods of use | |
| ZA939416B (en) | Modified lipolytic enzymes and their use | |
| AU4803997A (en) | Polymorphisms and new genes in the region of the human hemochromatosis gene | |
| ZA939415B (en) | Modified lipolytic enzymes and their use | |
| AU6819194A (en) | Isolated dna elements that direct pistil-specific and anther-specific gene expression and methods of using same | |
| GB9516059D0 (en) | Novel genes and proteins | |
| AU2823395A (en) | Novel compounds useful in modulating gene expression of retinoid responsive genes and/or having anti-ap-1 activity | |
| AU6010294A (en) | Modulators of gene expression | |
| AU2217397A (en) | Phosphoramidates and phosphinic amides, their use to modulate the activity of endothelin | |
| AU1347292A (en) | Methods of transcriptionally modulating gene expression of viral genes and other genes | |
| AU1059897A (en) | Dna comprising a neuron-specific transcriptional promoter and its use in a gene therapy vector | |
| AU2548095A (en) | Human inhibitor of apoptosis gene 1 | |
| AU1212797A (en) | The pig myogenin gene and method to identify polymorphisms related to muscle growth | |
| AU6263999A (en) | Human genes and gene expression products | |
| AU7137996A (en) | Materials and methods relating to the transfer of nucleic acid into quiescent cells | |
| AU7297594A (en) | Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines |